Helen Segil

Title: **Helen Segil: A Pioneer in Female Wellness Innovations**

Introduction

Helen Segil, based in Worcester, MA, is a remarkable inventor known for her innovative contributions to women's health. With her dedication to enhancing female well-being, she has made significant strides in addressing challenges faced by women due to medication.

Latest Patents

Helen Segil holds one patent titled "Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction." This groundbreaking invention focuses on compositions and methods that incorporate hemp and cannabidiol (CBD) for topical application. It specifically targets female sexual dysfunction that may occur as a side effect of antidepressant medications, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs).

Career Highlights

Helen is associated with Vella Bioscience, Inc., where she utilizes her expertise to develop effective solutions that improve women's health. Her work exemplifies the intersection of innovative science and compassionate care.

Collaborations

During her career, Helen has collaborated with notable professionals in the field, including Harin Padma-Nathan and Michael Frid. These partnerships highlight her commitment to advancing research and development in women's health.

Conclusion

Helen Segil's innovative approach to addressing female sexual dysfunction reflects her dedication to improving the lives of women. Through her patent and work at Vella Bioscience, she continues to pave the way for future advancements in health and wellness. Her contributions serve as an inspiration for aspiring inventors and a testament to the impact of innovation in the healthcare sector.